Phase I Trial of Intravenous Cisplatin-Topotecan Chemotherapy for Three Consecutive Days in Patients with Advanced Solid Tumors: Parallel Topotecan Escalation in Two Fixed Platinum Dosing Schemes

Publisher： Karger

E-ISSN： 1421-9794|51|2-3|154-161

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.2-3, 2005-06, pp. : 154-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I Study of Weekly Irinotecan Combined with Weekly Cisplatin in Patients with Advanced Solid Tumors

By  

Chemotherapy, Vol. 48, Iss. 4, 2002-09 ,pp. : 205-210

Karger

Access to resources Recommend Favorite

A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: The ITOV 01bis Study

By  

Chemotherapy, Vol. 61, Iss. 1, 2015-0 ,pp. : 15-22

Karger

Access to resources Recommend Favorite

A Dose Escalation Trial of Biweekly Docetaxel and Gemcitabine with Filgrastim or Pegfilgrastim for the Treatment of Patients with Advanced Solid Tumors

By  

Chemotherapy, Vol. 56, Iss. 2, 2010-04 ,pp. : 135-141

Karger

Access to resources Recommend Favorite

Topotecan in Platinum-Resistant Epithelial Ovarian Cancer

By  

Chemotherapy, Vol. 51, Iss. 6, 2005-11 ,pp. : 347-351

Karger

Access to resources Recommend Favorite

A Phase I Study of Pegylated Liposomal Doxorubicin and Irinotecan in Patients with Solid Tumors

By  

Chemotherapy, Vol. 55, Iss. 6, 2009-12 ,pp. : 441-445

Karger

Access to resources Recommend Favorite